Intellipharmaceutics International Inc (NASDAQ:IPCI)
| 1.84 Data as of May 24 |  +0.0312 / +1.72%Today’s Change | 1.57 Today|||52-Week Range 3.49 | -26.40% Year-to-Date |
Latest IPCI News | Press Releases
No recent news for Intellipharmaceutics International Inc.
Today’s Trading
| Previous close | 1.81 |
| Today’s open | 1.77 |
| Day’s range | 1.77 - 1.84 |
| Volume | 10,647 |
| Average volume (3 months) | 32,012 |
| Market cap | $36.3M |
| Dividend yield | -- |
Data as of 3:33pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | +48.92% |
| Earnings growth (this year) | +51.49% |
| Earnings growth (next 5 years) | +8.00% |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BLRXBioline RX Ltd | -0.05 | -2.98% |
| CPRXCatalyst Pharmaceuti... | +0.04 | +5.38% |
| ECTEEcho Therapeutics In... | +0.03 | +5.45% |
| ANTBAntriaBio Inc | -0.02 | -2.08% |
Data as of 3:59pm ET, 05/24/2013
Financials
| Next reporting date | July 17, 2013 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$15.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chairman, CEO & Co-Chief Scientific Officer Isa Odidi, PhD, MBA |
President, Chief Operating Officer & Director Amina Odidi, PhD |
Corporate headquarters Toronto, Ontario |
Forecasts
